PSYLO ANNOUNCES SPONSORED RESEARCH AGREEMENT WITH DAIICHI SANKYO TO DEVELOP NON-HALLUCINOGENIC PSYCHIATRIC THERAPIES

psylo_news
Written By Dilara Bahceci

The Sponsored Research Agreement will help advance antidepressant treatments for patients in need

Dilara Bahceci
Previous

Psylo announces sponsored research agreement with Daiichi Sankyo to develop non-hallucinogenic psychiatric therapies
Next

Australia’s food, drug and finance regulators can be progressive